Early Experience with the Senhance Surgical System in Bariatric Surgery

Abstract

Background and Objectives: Robotic-assisted surgery advancements have paralleled growing bariatric surgery demands.The Senhance robotic platform offers an alternative to the da Vinci surgical system but there are limited studies evaluating the Senhance system in bariatric surgery.This study aims to review a single surgeon's experience comparing outcomes between traditional laparoscopic and Senhance-assisted sleeve gastrectomy.Materials and Methods: All sleeve gastrectomies performed laparoscopically, Senhance-assisted, or da Vinciassisted by a single surgeon at an academic center from January 2019 to July 2021 were retrospectively reviewed.Primary outcomes and quality measures were 30-day complications, operative times and length of stay.Results: A total of 268 patients, including 162 laparoscopic, 92 Senhance, and 14 da Vinci cases, were included.Operative times were significantly longer with Senhance (115.7 min) and da Vinci (122.7 min), compared to laparoscopic (94.8 min, P < .0001).Length of stay (measured in days) was significantly longer in the Senhance (1.8) and da Vinci (2.2) groups compared to laparoscopic cases (1.5, P < .0001).These differences remained significant after controlling for age, sex and body mass index.30-day complication rates were 8.7% (n 5 8) in the Senhance group, 7.1% (n 5 1) in the da Vinci group and 2.5% (n 5 4) in the laparoscopic group (P 5 .0567). Conclusion:Senhance-assisted sleeve gastrectomy is safe in bariatric surgery and comparable to laparoscopic sleeve gastrectomy with respect to 30-day complications.